Key result
Combining baPWV, hsa_circ_0093884, and CGA scores achieves an excellent 0.94 AUC for diagnosing Alzheimer's disease.
Why the study?
Vascular aging plays a key role in Alzheimer's disease pathogenesis, prompting evaluation of arterial stiffness and endothelial progenitor-derived exosomal circRNAs as diagnostic biomarkers.
Do baPWV and EPC-Exosomal hsa_circ_0093884 levels accurately diagnose Alzheimer's disease compared to mild or no cognitive impairment?
Observational (n=125)
Do baPWV and EPC-Exosomal hsa_circ_0093884 levels accurately diagnose Alzheimer's disease compared to mild or no cognitive impairment?
Effect estimate: AUC 0.943 (95% CI 0.881-1.000)
Arterial stiffness (baPWV) and EPC-Exosomal hsa_circ_0093884 serve as strong diagnostic biomarkers for Alzheimer's disease, supporting a vascular-neuronal link in neurodegeneration.
Background Vascular aging plays a key role in the pathogenesis of Alzheimer’s disease (AD). This study evaluated the diagnostic value of arterial stiffness and endothelial progenitor CD34 + progenitor-derived exosomal circRNAs (EPC-Exos circRNAs) in AD, and examined their associations with Comprehensive Geriatric Assessment (CGA) measures. Methods We measured brachial-ankle pulse wave velocity (baPWV) and conducted CGA in subjects with AD (n = 58), mild cognitive impairment (MCI, n = 31), and non-cognitive impairment (NCI, n = 36). Plasma levels of SIRT1-derived circRNAs (including hsa_circ_0093884) within EPC-Exos were quantified. Logistic regression and ROC curve analyses were used to assess diagnostic performance, with internal validation performed using bootstrapping (1,000 resamplings) to evaluate model stability. Aβ1-42-treated SH-SY5Y cells were used as a neuronal model to validate the downstream neuroprotective effects of circRNA. The miR-375/SIX4 regulatory axis was investigated using bioinformatics prediction, biotin-RNA pull-down, dual-luciferase reporter assays, and co-transfection experiments. Results Compared to MCI and NCI groups, AD patients exhibited significantly higher baPWV and lower levels of EPC-Exosomal hsa_circ_0093884 ( P < 0.01). A composite model incorporating baPWV, hsa_circ_0093884, and CGA scores showed excellent diagnostic performance (AUC = 0.943; 95% CI: 0.881–1.000), with the robustness of key predictors confirmed by bootstrap validation. In Aβ1-42-treated SH-SY5Y cells, overexpression of hsa_circ_0093884 increased cell viability and reduced apoptosis, whereas knockdown further decreased viability and promoted apoptosis. Mechanistically, hsa_circ_0093884 directly interacted with miR-375 and regulated SIX4 expression. Conclusion EPC-Exosomal hsa_circ_0093884 and baPWV are valuable diagnostic biomarkers associated with Alzheimer’s disease. The hsa_circ_0093884/miR-375/SIX4 axis offers a novel therapeutic target, supporting a potential vascular-neuronal axis connecting vascular aging to neurodegeneration.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted an observational in Alzheimer's disease (n=125). Composite model of baPWV, hsa_circ_0093884, and CGA scores vs. Mild cognitive impairment and non-cognitive impairment groups was evaluated on Diagnostic performance for Alzheimer's disease (AUC 0.943, 95% CI 0.881-1.000). A composite model incorporating baPWV, hsa_circ_0093884, and CGA scores demonstrated excellent diagnostic performance for Alzheimer's disease (AUC 0.943; 95% CI 0.881-1.000).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: